|PRODUCT NAME||CATALOG #||UNIT||PRICE||QTY||FAVORITES|
|c-Abl Antibody (24-11)||sc-23||100 µg/ml||$279.00||
See how others have used c-Abl Antibody (24-11). Click on the entry to view the PubMed entry .
PMID: # 26603102
Contreras, PS. et al. 2016. Neuronal gene repression in Niemann-Pick type C models is mediated by the c-Abl/HDAC2 signaling pathway. Biochim. Biophys. Acta. 1859: 269-79.
PMID: # 25450971
Bernusso, VA. et al. 2015. Imatinib restores VASP activity and its interaction with Zyxin in BCR-ABL leukemic cells. Biochimica et biophysica acta. 1853: 388-95.
PMID: # 24569990
Wie, SM. et al. 2014. Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage. J. Biol. Chem.. 289: 10900-10908.
PMID: # 23894305
Liu, Y. et al. 2013. Low expression of miR-196b enhances the expression of BCR-ABL1 and HOXA9 oncogenes in chronic myeloid leukemogenesis. PLoS ONE. 8: e68442.
PMID: # 22665498
Wetzel, D.M. et al. 2012. The Abl and Arg kinases mediate distinct modes of phagocytosis and are required for maximal Leishmania infection. Molecular and cellular biology. 32: 3176-86.
PMID: # 21690296
Chen A et al. 2011. c-Abl-Mediated Tyrosine Phosphorylation of the T-bet DNA-Binding Domain Regulates CD4+ T-Cell Differentiation and Allergic Lung Inflammation. Mol Cell Biol. . 31: 3445-3456.
PMID: # 20717963
Chen, JY. et al. 2011. Bcr-Abl-induced tyrosine phosphorylation of Emi1 to stabilize Skp2 protein via inhibition of ubiquitination in chronic myeloid leukemia cells. J. Cell. Physiol.. 226: 407-413.
PMID: # 21386967
Vilas-Zornoza, A. et al. 2011. Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia. PLoS ONE. 6: -.
PMID: # 21569802
Machado-Neto, JA. et al. 2011. Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells. Biochim. Biophys. Acta. 1813: 1404-1411.
PMID: # 21220747
Warsch, W. et al. 2011. High STAT5 levels mediate imatinib resistance and indicate disease progression in chronic myeloid leukemia. Blood. 117: 3409-3420.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2017 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.